These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 11966949

  • 1. Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics.
    De BK, Das D, Sen S, Biswas PK, Mandal SK, Majumdar D, Maity AK.
    J Gastroenterol Hepatol; 2002 Feb; 17(2):183-9. PubMed ID: 11966949
    [Abstract] [Full Text] [Related]

  • 2. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R, Moitinho E, Piqueras B, Casado M, García-Pagán JC, de Diego A, Bosch J.
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [Abstract] [Full Text] [Related]

  • 3. Carvedilol or propranolol in portal hypertension? A randomized comparison.
    Hobolth L, Møller S, Grønbæk H, Roelsgaard K, Bendtsen F, Feldager Hansen E.
    Scand J Gastroenterol; 2012 Apr; 47(4):467-74. PubMed ID: 22401315
    [Abstract] [Full Text] [Related]

  • 4. A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis.
    Kim SG, Kim TY, Sohn JH, Um SH, Seo YS, Baik SK, Kim MY, Jang JY, Jeong SW, Lee B, Kim YS, Suk KT, Kim DJ.
    Am J Gastroenterol; 2016 Nov; 111(11):1582-1590. PubMed ID: 27575713
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
    Reiberger T, Ulbrich G, Ferlitsch A, Payer BA, Schwabl P, Pinter M, Heinisch BB, Trauner M, Kramer L, Peck-Radosavljevic M, Vienna Hepatic Hemodynamic Lab.
    Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
    [Abstract] [Full Text] [Related]

  • 7. Hemodynamic effect of carvedilol vs. propranolol in cirrhotic patients: Systematic review and meta-analysis.
    Aguilar-Olivos N, Motola-Kuba M, Candia R, Arrese M, Méndez-Sánchez N, Uribe M, Chávez-Tapia NC.
    Ann Hepatol; 2014 Nov; 13(4):420-8. PubMed ID: 24927613
    [Abstract] [Full Text] [Related]

  • 8. Acute and 14-day hepatic venous pressure gradient response to carvedilol and nebivolol in patients with liver cirrhosis.
    Silkauskaitė V, Kupčinskas J, Pranculis A, Jonaitis L, Petrenkienė V, Kupčinskas L.
    Medicina (Kaunas); 2013 Nov; 49(11):467-73. PubMed ID: 24823927
    [Abstract] [Full Text] [Related]

  • 9. Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.
    Reiberger T, Ferlitsch A, Payer BA, Pinter M, Homoncik M, Peck-Radosavljevic M, Vienna Hepatic Hemodynamic Lab.
    J Gastroenterol; 2012 May; 47(5):561-8. PubMed ID: 22170417
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis.
    Sinagra E, Perricone G, D'Amico M, Tinè F, D'Amico G.
    Aliment Pharmacol Ther; 2014 Mar; 39(6):557-68. PubMed ID: 24461301
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A, Hernández-Gea V, Bosch J.
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [Abstract] [Full Text] [Related]

  • 15. An advance in the treatment of portal hypertension?
    Wong F, Blendis L.
    Gastroenterology; 2000 Apr; 118(4):802-3. PubMed ID: 10734033
    [No Abstract] [Full Text] [Related]

  • 16. Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes.
    Bruha R, Vitek L, Petrtyl J, Lenicek M, Urbanek P, Zelenka J, Jachymova M, Svestka T, Kalab M, Dousa M, Marecek Z.
    Scand J Gastroenterol; 2006 Dec; 41(12):1454-63. PubMed ID: 17101577
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis.
    Forrest EH, Bouchier IA, Hayes PC.
    J Hepatol; 1996 Dec; 25(6):909-15. PubMed ID: 9007720
    [Abstract] [Full Text] [Related]

  • 20. Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension.
    Sekiyama T, Komeichi H, Nagano T, Ohsuga M, Terada H, Katsuta Y, Satomura K, Aramaki T.
    Arzneimittelforschung; 1997 Apr; 47(4):353-5. PubMed ID: 9150854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.